ruihua xu
Sun Yat-Sen University Cancer Center · Sun Yat-sen University Cancer Center (SYSUCC) · Cancer Center of SUN YAT-senU
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name ruihua xu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:06 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07915921 · A Phase Ib/II Study of GFH276 in Combination With Chemotherapy (± Bevacizumab) or Cetuximab in Patients With RAS-mutant Metastatic Colorectal CancerGenfleet Therapeutics (Shanghai) Inc. · not yet recruiting · CRC · principal investigator
- Ph1NCT07809607 · A Study to Evaluate YF087 in Subjects With MSI-H or dMMR Advanced Solid TumorsInventisBio Co., Ltd · not yet recruiting · Advanced Solid Tumor Cancer · principal investigator
- Ph1/Ph2NCT07791758 · A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal CarcinomaNanjing Leads Biolabs Co.,Ltd · recruiting · Metastatic Colorectal Carcinoma · principal investigator
- Ph3NCT07412613 · Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon CancerAkeso · recruiting · Resectable Colon Cancer, MSI-H/dMMR Colorectal Cancer · principal investigator
- Ph1NCT07269899 · A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid TumorsSun Yat-sen University · recruiting · Solid Tumor Cancer, Cancer · principal investigator
- Ph2NCT07133750 · PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal CancerBiotheus Inc. · recruiting · CRC (Colorectal Cancer) · principal investigator
- Ph1/Ph2NCT07056777 · Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal CancerZhejiang Doer Biologics Co., Ltd. · recruiting · Gastrointestinal Cancer · principal investigator
- Ph2NCT07021950 · AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal CancerSun Yat-sen University · not yet recruiting · Colorectal Cancer, Ivonescimab · principal investigator
- Ph1/Ph2NCT07019779 · Study of CM518D1 in Patients With Advanced Solid TumorsKeymed Biosciences Co.Ltd · recruiting · Advanced Solid Tumors · principal investigator
- Ph3NCT06976190 · A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaLepu Biopharma Co., Ltd. · recruiting · Recurrent or Metastatic Nasopharyngeal Carcinoma · principal investigator
- Ph1NCT06800196 · A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 AlterationsKinoTeck Therapeutics Co., Ltd · recruiting · Solid Tumors With FGFR2 Alterations, Adult · principal investigator
- Ph1/Ph2NCT06781125 · One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid TumorsImmorna Biotherapeutics, Inc. · recruiting · Malignant Solid Tumors · principal investigator
- Ph3NCT06656091 · A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell CarcinomaShanghai Runshi Pharmaceutical Technology Co., Ltd · not yet recruiting · Advanced Oesophageal Squamous Cell Carcinoma · principal investigator
- Ph3NCT06640361 · A Study of Olverembatinib in SDH-deficient GIST.Ascentage Pharma Group Inc. · recruiting · GIST · study chair
- Ph3NCT06501664 · Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCCRui-hua Xu, MD, PhD · not yet recruiting · Esophageal Cancer · principal investigator
- Ph1NCT06500052 · A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Esophageal Cancer, Gastric Cancer, Pancreatic Cancer · principal investigator
- Ph1/Ph2NCT06376136 · A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic TumorsBio-Thera Solutions · active not recruiting · Advanced Solid Tumors · principal investigator
- Ph3NCT06296706 · A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd. · recruiting · Gastric Cancer · principal investigator
- Ph1NCT06223256 · A Study of NBL-028 in Patients With Advanced Solid TumorsNovaRock Biotherapeutics, Ltd · recruiting · Advanced Solid Tumor · principal investigator
- Ph1NCT06166472 · A Study to Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of AK132 in Advanced Malignant Solid TumorAkeso · unknown · Advanced Malignant Solid Tumor · principal investigator
- Ph3NCT05978050 · Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction AdenocarcinomaBiotech Pharmaceutical Co., Ltd. · unknown · Gastric or Esophagogastric Junction Adenocarcinoma · principal investigator
- Ph1NCT05979155 · A Study of NWY001 in Subjects With Advanced Solid TumorsChipscreen Biosciences, Ltd. · recruiting · Advanced Solid Tumor · principal investigator
- Ph2NCT05962502 · Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line TherapySun Yat-sen University · recruiting · Metastatic Colorectal Cancer · principal investigator
- Ph3NCT05918094 · Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction AdenocarcinomaSun Yat-sen University · recruiting · Gastric Cancer · principal investigator
- Ph1NCT05877651 · MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.HRYZ Biotech Co. · completed · Solid Tumors · principal investigator
- Ph1NCT05781386 · A Phase I Trial of SIM1811-03 in Subjects With Advanced TumorsJiangsu Simcere Biologics Co., Ltd · unknown · Advanced Solid Tumor, Cutaneous T Cell Lymphoma · principal investigator
- Ph3NCT05768503 · Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRCSun Yat-sen University · recruiting · Metastatic Microsatellite-stable Colorectal Cancer · principal investigator
- Ph1/Ph2NCT05745623 · Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System TumorsBeijing InnoCare Pharma Tech Co., Ltd. · recruiting · Advanced Solid Tumors Harboring NTRK Fusion, Primary Central Nervous System Tumors Harboring NTRK Fusion · principal investigator
- Ph2NCT05705635 · A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd. · unknown · Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction · study chair
- Ph1/Ph2NCT05688605 · A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid TumorsLepu Biopharma Co., Ltd. · recruiting · Advanced Solid Tumors · principal investigator
- N/ANCT05557955 · Identification of Breath Biomarkers in Esophageal CancerMian XI · completed · Esophageal Squamous Cell Carcinoma · study director
- Ph2NCT05520619 · Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)Sun Yat-sen University · active not recruiting · Esophageal Squamous Cell Carcinoma, Locally Advanced Esophageal Squamous Cell Carcinoma · principal investigator
- Ph1NCT05502393 · A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid TumorsShanghai Junshi Bioscience Co., Ltd. · active not recruiting · Advanced Solid Tumors · principal investigator
- Ph1NCT05385692 · A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Locally Advanced or Metastatic Digestive Tract Tumors, Solid Tumor · principal investigator
- Ph2NCT05163483 · Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric CancerRuihua Xu · unknown · Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma · principal investigator
- Ph2NCT05126719 · A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal CarcinomaLepu Biopharma Co., Ltd. · active not recruiting · Recurrent or Metastatic Nasopharyngeal Carcinoma · principal investigator
- Ph1NCT04991129 · The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced CancerSuzhou Junjing BioSciences Co., Ltd. · terminated · Advanced Hematologic Malignancies, Advanced Solid Tumors · principal investigator
- Ph1NCT04868344 · A Study of MRG003 in Patients With Advanced Solid TumorsLepu Biopharma Co., Ltd. · completed · Advanced Solid Tumors · principal investigator
- Ph1NCT04805307 · Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901Keymed Biosciences Co.Ltd · completed · Advanced Solid Tumor, Gastric Cancer(Including Gastroesophageal Junction Adenocarcinoma), Pancreatic Cancer · principal investigator
- Ph2NCT04784520 · A Study of HA121-28 Tablets in Advanced Biliary Tract CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd. · terminated · Biliary Tract Cancer · principal investigator
- Ph2NCT04724239 · Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal CarcinomaSun Yat-sen University · unknown · Advanced Microsatellite Stable Colorectal Cancer, Metastatic Microsatellite-stable Colorectal Cancer · principal investigator
- Ph2/Ph3NCT04547166 · A Clinical Study to Evaluate Efficacy and Safety of Serplulimab(HLX10) Combined With Bevacizumab(HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)Shanghai Henlius Biotech · recruiting · Metastatic Colorectal Cancer · study chair
- Ph2NCT04547101 · A Study of AK104 in Subjects With Locally Advanced Unresectable or Metastatic MSI-H/dMMR Solid TumorsAkeso · terminated · MSI-H/dMMR Solid Tumor · principal investigator
- Ph3NCT04262635 · Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal CancerSun Yat-sen University · unknown · Colorectal Cancer · study chair
- N/ANCT04230200 · Prospective Screening Programme for Malignant TumorsSun Yat-sen University · unknown · Hematologic Tests, Malignant Tumor · principal investigator
- N/ANCT04228614 · Evaluation of Somatic Mutation Spectrum as Biomarker for Survival Outcome in Chinese CRCSun Yat-sen University · unknown · Colorectal Cancer · study director
- Ph2NCT04220307 · A Study of a PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal CarcinomaAkeso · completed · Nasopharyngeal Carcinoma · study chair
- Ph2NCT03906565 · Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal CancerBeijing Biostar Pharmaceuticals Co., Ltd. · suspended · Advanced or Metastatic CRC · principal investigator
- Ph3NCT03829969 · Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell CarcinomaShanghai Junshi Bioscience Co., Ltd. · completed · Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy · principal investigator
- Ph3NCT03691090 · Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal CancerJiangsu HengRui Medicine Co., Ltd. · completed · Advanced Esophageal Cancer · principal investigator
- Ph1NCT03594422 · A Study of HQP1351 in Patients With GIST or Other Solid TumorsAscentage Pharma Group Inc. · recruiting · Gastrointestinal Stromal Tumor (GIST), Solid Tumor, Adult · principal investigator
- Ph3NCT03581786 · The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal CancerShanghai Junshi Bioscience Co., Ltd. · completed · Recurrent or Metastatic NPC · principal investigator
- Ph1NCT03544905 · Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33Haihe Biopharma Co., Ltd. · completed · Advanced Solid Tumors · principal investigator
- N/ANCT03312374 · ctDNA as a Prognostic Marker for Postoperative Relapse in Early and Intermediate Stage Colorectal CancerSun Yat-sen University · unknown · Colorectal Cancer · study chair
- Ph3NCT03223376 · A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)Hutchison Medipharma Limited · completed · Advanced Gastric Cancer · principal investigator
- Ph1NCT03182673 · The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid TumorsJiangsu HengRui Medicine Co., Ltd. · terminated · Solid Tumor · principal investigator
- Ph1NCT03034304 · A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid TumorsHRYZ Biotech Co. · terminated · Advanced Solid Tumors · principal investigator
- Ph1NCT02968485 · Phase I Study of SHR7390 in Patients With Advanced Solid TumorsJiangsu HengRui Medicine Co., Ltd. · unknown · Solid Tumor · principal investigator
- Ph1/Ph2NCT02915432 · The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCCShanghai Junshi Bioscience Co., Ltd. · unknown · Gastric Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Nasopharyngeal Carcinoma · principal investigator
- Ph1NCT02857166 · Study of JS001 in Participants With Advanced Solid TumorsShanghai Junshi Bioscience Co., Ltd. · completed · Solid Tumors · principal investigator
- Ph3NCT02390947 · Safety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma(FACT)Jiangsu HengRui Medicine Co., Ltd. · completed · Colorectal Cancer Metastatic, Colorectal Cancer Recurrent · principal investigator
- Ph2NCT02229045 · Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric CancerSun Yat-sen University · unknown · Gastric Caner · principal investigator
- Ph2NCT02229058 · Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric CancerSun Yat-sen University · completed · Gastric Cancer · principal investigator
- Ph2NCT02090153 · Study of S-1 Plus LV for Advanced Gastric CancerSun Yat-sen University · completed · Gastric Cancer · principal investigator
- Ph2NCT02027363 · Maintenance Treatment With Capecitabine in Colorectal Cancer PatientsSun Yat-sen University · unknown · Colorectal Neoplasms, Neoplasms Metastasis · principal investigator
- Ph2NCT02004769 · Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric CancerSun Yat-sen University · completed · Stomach Neoplasms, Neoplasms Metastasis, ERBB2 Gene Amplification · principal investigator
- Ph3NCT01996306 · A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRCEpidemiological and Clinical Research Information Network · completed · Colorectal Neoplasms, Neoplasm Metastasis, Intestinal Neoplasms · principal investigator
- Ph3NCT01824459 · S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma PatientsSun Yat-sen University · completed · Gastric Cancer · principal investigator
- Ph2NCT01762293 · A Study of Famitinib in Patients With Advanced Colorectal CancerJiangsu HengRui Medicine Co., Ltd. · completed · Colorectal Cancer, Colorectal Cancer Metastatic, Colorectal Cancer Recurrent · principal investigator
- N/ANCT01549067 · The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation SurveyChinese Medical Doctor Association · unknown · Advanced Malignant Neoplasm, Colorectal Cancer · principal investigator
- Ph3NCT01198392 · Trial of S-1 Plus Cisplatin in Gastric CancerSun Yat-sen University · unknown · Gastric Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:06 UTC. The ranking covers the 200 most relevant of 419 PubMed records, and a shared surname and initials can bring in a namesake. All 419 on PubMed
- 829 citationsRCR 26.1
- 778 citationsRCR 69.3
- Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.Nat Mater · 2017703 citationsRCR 23.2
- 689 citationsRCR 34.6
- 664 citationsRCR 19.7
- 627 citationsRCR 54.7
- Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.Cancer Cell · 2022462 citationsRCR 28.6
- Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.Lancet Oncol · 2023433 citationsRCR 38.6
- 379 citationsRCR 11.7
- 356 citationsRCR 18.6